MD Stock Analysis: Buy, Sell, or Hold?
MD - Pediatrix Medical Group, Inc.
$20.70
-0.69 (-3.23%)
▼
5d:
-2.31%
30d:
+4.86%
90d:
-5.13%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When MD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.95
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$16.74
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MD is currently trading at $20.70, which is considered extended relative to its 30-day fair value range of $19.51 to $20.62. The stock's valuation (Forward PE: 8.9) is in line with its historical norms (9.5). Remarkably, the market is currently pricing in an annual earnings decline of 2.2% over the next few years. This pessimistic expectation contrasts with the company's recent 11.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, MD is in a strong downtrend. Immediate support is located at $19.65, while resistance sits at $21.52. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: MD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MD is in a strong downtrend. Immediate support is located at $19.65, while resistance sits at $21.52. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: MD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$19.51 -
$20.62
Company Quality Score
61/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
55.8%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- NEUTRAL: Near Wall St target ($21.33)
Fair Price Analysis
30-Day Fair Range
$19.51 -
$20.62
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$1.46
(7.1%)
Support & Resistance Levels
Support Level
$19.65
Resistance Level
$21.52
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.90
Wall Street Target
$21.33
(+3.1%)
Revenue Growth (YoY)
-1.7%
Earnings Growth (YoY)
11.4%
Profit Margin
8.6%
Valuation Discount vs History
-2.2% cheaper
PE vs Historical
8.9 vs 9.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.2%
(market-implied from PE analysis)
1-Year Target
$20.24
(-2%)
2-Year Target
$19.80
(-4%)
3-Year Target
$19.36
(-7%)
3-Yr Target (if PE normalizes)
(PE: 9→10)
$20.67
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 4.1%)
$58.68
(+184%)
Base:
(SPY PE: 8.9, Growth: 4.1%)
$23.36
(+13%)
Bear:
(PE: 7.6, Growth: 4.1%)
$19.86
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 10.15 | Current EPS (TTM): $1.94
Bull Case
$25.98
(+26%)
Analyst growth 19.9%, PE expands to 11.2
Base Case
$23.62
(+15%)
Market implied 19.9%, PE stable at 10.2
Bear Case
$13.40
(-35%)
Severe decline -20.0%, PE contracts to 8.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.9 to 9.5
Stabilization Target:
$22.10
(+6.8%)
PE Expansion Potential:
+6.8%
Share & Embed Analysis
Last updated: April 02, 2026 9:19 AM ET
Data refreshes hourly during market hours. Next update: 10:19 AM
Data refreshes hourly during market hours. Next update: 10:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark S Ordan
SELL
23000 shares
2025-12-15
Michael A Rucker
SELL
10478 shares
2025-11-17
Laura A Linynsky
SELL
10000 shares
2025-11-06
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 58 HOLD |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 47 HOLD |
|
ASTH
Astrana Health Inc |
STRONG BUY
12 analysts |
$36 | 65 BUY |
